LAGUNA HILLS, Calif., May 05, 2016 (GLOBE NEWSWIRE) — Sonendo®, Inc., the developer of a disruptive technology for the endodontic marketplace, announced today that the GentleWave® System has been chosen as a finalist in this year’s Medical Design Excellence Awards (MDEA) for its compelling and innovative design. MDEA are the premier awards for the medical technology industry that honor the highest caliber medical devices on the market today.
Disruptive innovation for the endodontic market is at the center of Sonendo’s product development efforts as evidenced by the GentleWave® System. The GentleWave System leverages minimally-invasive, proprietary technology to clean the entire root canal system. As opposed to conventional endodontic files that only touch 50%-65% of the canal surface, the GentleWave System reaches deep into dentin tubules and other complex anatomies that cannot be accessed with conventional techniques1-3.
Bjarne Bergheim, President and CEO, stated “Our mission is Saving Teeth Through Sound Science® and delivering on our value proposition to provide a better patient outcome through exponential improvements in Clinical Efficacy, and Treatment Efficiency. On behalf of the entire Sonendo organization, we are honored to be a finalist for the 2016 Medical Design Excellence Awards.”
To learn more about Sonendo and the GentleWave System please visit www.sonendo.com.
1Paque F et al. (2010) J Endod. 4:703-7 2 Molina B et al. (2105) J Endod. 41:1701–5
3 Vandrangi P. Dentistry. 2016; 6:366. (In Press)
About Sonendo®
Sonendo, Inc. is a privately-held, venture-backed company developing innovative and disruptive technologies to transform dentistry by Saving Teeth Through Sound Science®. The first commercially available product from Sonendo, the GentleWave® System, available in the US, shows significant improvements in clinical efficacy, and treatment efficiency when compared to conventional root canal techniques4-5. For more information please visit: www.sonendo.com.
4Molina B et al. (2015) J Endod. 41:1701-05. 5Haapasalo M et al. (2014) J Endod. 40:1178-81.
Forward-Looking Statements
This announcement contains forward-looking statements that are based on management’s beliefs, assumptions and expectations and on information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations with respect to the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.
CONTACT: Media Contact: Bob Guyatt Vice President of Marketing 949.766.3636
Source: Medical